secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2025-07-15T23:59:59+00:00
Accession:  0001193125-25-159400
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ikena stockholders approve Inmagene merger; 1:12 reverse split; combined co. to trade as IMA
--------------------------------------------------------------------------------

- All 7 proposals approved including merger issuance of IKNA shares >20% and reverse split.
- 1-for-12 reverse stock split to reduce outstanding shares from ~48.2M to ~4M.
- Merger and concurrent financing expected to close around end of July 2025.
- Combined company will be ImageneBio, Inc., trading on Nasdaq under ticker IMA.
- New CUSIP for post-split common stock: 45175G 207.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312525159400/0001193125-25-159400-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312525159400/d42277d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-159400

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer